Liver disease Patients' vaccine response under the microscope
NCT ID NCT05669677
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how people with chronic liver disease (like hepatitis B, C, or fatty liver) respond to COVID-19 vaccines. About 233 adults had three visits over a year to check their immune response and see if they got COVID-19. The goal was to understand if liver disease affects vaccine protection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple scan and blood test outsmart liver cancer?
- A new MRI technique could see inside the Liver's metabolism without a biopsy
- Can a new injection tame chronic hepatitis b?
- Could a common b vitamin tame fatty liver?
- Can a sugar test reveal how fatty liver begins in obese adolescents?
- Double liver trouble: does having both hepatitis b and fatty liver speed up disease?